At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12,297 enrolled
Drug / intervention
no intervention is planned.other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Heidelberg Registry of Atrial Fibrillation
In Brief
An observational study evaluating no intervention is planned. for Atrial Fibrillation. Completed, enrolled 12,297 participants across 1 site.
Detailed Summary
The single-center HERA AFIb registry was created to assess real-world prevalence, demographic characteristics and management of patients with atrial fibrillation (AF) in the era of novel oral anticoagulant regimes (NOAC) presenting in the emergency department (ED) of University of Heidelberg
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2009
Primary CompletionApr 2020
First PostedAug 2023
TodayJul 2026
First PostedAug 16, 2023
Enrollment StartJun 1, 2009
Primary CompletionApr 1, 2020
TodayJul 2, 2026
Enrollment to primary: 10.8 yearsPosted 2.9 years ago
Interventions
no intervention is planned.other
no intervention is planned.